New hope for Hard-to-Treat ovarian cancer: drug combo trial launches
Disease control
Recruiting now
This study tests a combination of two drugs, vismodegib and atezolizumab, in people with ovarian, fallopian tube, or peritoneal cancer that no longer responds to platinum-based chemotherapy. The goal is to see if this treatment can shrink tumors or slow the disease. About 48 part…
Phase: PHASE2 • Sponsor: Ronald Buckanovich • Aim: Disease control
Last updated May 17, 2026 06:15 UTC